Skip to content

Inside DNAnexus

Product updates, industry insights, opinions and references. From the team powering the Genomics Revolution.

AWS Re:Invent – How Cloud Computing is Redefining Research

AWS reInventWe were honored to receive an invitation to speak, together with Amazon Web Services (AWS) Scientific Computing and Regeneron Genetics Center, at the 2014 AWS re:Invent conference being held next week in Las Vegas.  As a member of the AWS Partner Network Life Science Competency Program, we work with AWS to provide genomic analysis and data management solutions for biopharma, diagnostic test providers, genome research centers, and sequencing service providers.

By combining DNAnexus vertical market expertise with AWS’s cloud computing technology we deliver an enterprise-grade solution for genome informatics and data management.  We recently announced that the DNAnexus platform is powering novel collaborations between the Regeneron Genetics Center and leading healthcare providers. Jeffrey Reid, PhD, head of genome informatics at the RGC will be discussing in detail how the RGC is using the DNAnexus platform to integrate sequencing data with de-identified clinical records from healthcare partners. To date, the RGC has sequenced samples from more than 10,000 individuals and operating at a capacity to sequence more than 50,000 samples per year.

Talk details:

HLS303 – How Cloud Computing is Redefining Research: Secure, Collaborative Science at Scale
5:30 PM, Thursday, November 13th, Venetian Delfino Room (4002)


Jeffrey Reid, PhD – Director and Head of Genome Informatics, Regeneron Genetics Center
Omar Serang – Chief Cloud Officer, DNAnexus
Angel Pizarro – Technical Business Development Manager, Amazon Web Services

DNAnexus delivers out-of-the-box job features in support of genomic research and collaboration, providing an extensive list of value-adds on top of AWS, including:

  • Large-scale job control, supporting workflows using 1000s of nodes
  • High-performance storage framework to serve large objects to 1000s of nodes
  • Resource consumption tracking and alerts to avoid invoice surprises
  • Application level identity and access management for secure sharing of data and tools globally

The DNAnexus platform is employed by organizations and consortia globally to integrate data, enable collaboration, and accelerate discovery, and has been used to investigate conditions such as cardiovascular disease, cancer, and Alzheimer disease. You can learn more about DNAnexus-supported initiatives here.

About DNAnexus

DNAnexus the leader in biomedical informatics and data management, has created the global network for genomics and other biomedical data, operating in 33 countries including North America, Europe, China, Australia, South America, and Africa. The secure, scalable, and collaborative DNAnexus Platform helps thousands of researchers across a spectrum of industries — biopharmaceutical, bioagricultural, sequencing services, clinical diagnostics, government, and research consortia — accelerate their genomics programs.

The DNAnexus team is made up of experts in computational biology and cloud computing who work with organizations to tackle some of the most exciting opportunities in human health, making it easier—and in many cases feasible—to work with genomic data. With DNAnexus, organizations can stay a step ahead in leveraging genomics to achieve their goals. The future of human health is in genomics. DNAnexus brings it all together.